The Role of Dipeptidyl Peptidase – 4 Inhibitors in Diabetic Kidney Disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Dipeptidyl Peptidase – 4 Inhibitors in Diabetic Kidney Disease
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-08-28
DOI
10.3389/fimmu.2015.00443
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition
- (2015) Sen Shi et al. KIDNEY INTERNATIONAL
- Dipeptidyl peptidase-4 deficiency protects against experimental diabetic nephropathy partly by blocking the advanced glycation end products-receptor axis
- (2015) Takanori Matsui et al. LABORATORY INVESTIGATION
- DPP4 inhibitors dodge cardiovascular bullet
- (2015) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- The DPP-4 inhibitor linagliptin and the GLP-1 receptor agonist exendin-4 improve endothelium-dependent relaxation of rat mesenteric arteries in the presence of high glucose
- (2015) S.M. Salheen et al. PHARMACOLOGICAL RESEARCH
- Prevention of Obesity-Induced Renal Injury in Male Mice by DPP4 Inhibition
- (2014) Ravi Nistala et al. ENDOCRINOLOGY
- Linagliptin Blocks Renal Damage in Type 1 Diabetic Rats by Suppressing Advanced Glycation End Products-Receptor Axis
- (2014) S. Nakashima et al. HORMONE AND METABOLIC RESEARCH
- Dipeptidyl peptidase IV inhibitor protects against renal interstitial fibrosis in a mouse model of ureteral obstruction
- (2014) Hye Sook Min et al. LABORATORY INVESTIGATION
- DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat
- (2014) Ravi Nistala et al. Obesity
- A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site
- (2013) Mika Nabeno et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes
- (2013) Ryo Kodera et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Glypican-3-mediated inhibition of CD26 by TFPI: a novel mechanism in hematopoietic stem cell homing and maintenance
- (2013) S. Khurana et al. BLOOD
- The role of dipeptidyl peptidase 4 in hematopoiesis and transplantation
- (2013) Heather O’Leary et al. CURRENT OPINION IN HEMATOLOGY
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- Interaction of dipeptydil peptidase IV with amyloid peptides
- (2013) Svetlana Sharoyan et al. NEUROCHEMISTRY INTERNATIONAL
- The Cardiovascular Safety of Diabetes Drugs — Insights from the Rosiglitazone Experience
- (2013) William R. Hiatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells—Renoprotection in Diabetic Nephropathy?
- (2013) Usha Panchapakesan et al. PLoS One
- Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis
- (2012) Hal E Broxmeyer et al. NATURE MEDICINE
- Novel aspects of cellular action of dipeptidyl peptidase IV/CD26
- (2011) Siegfried Ansorge et al. BIOLOGICAL CHEMISTRY
- High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV
- (2011) C. Marchetti et al. DIABETOLOGIA
- Pharmacology of Dipeptidyl Peptidase-4 Inhibitors
- (2011) Roberta Baetta et al. DRUGS
- Diabetic Nephropathy Amelioration by a Low-Dose Sitagliptin in an Animal Model of Type 2 Diabetes (Zucker Diabetic Fatty Rat)
- (2011) Cristina Mega et al. Experimental Diabetes Research
- Peptidomics of the Prolyl Peptidases
- (2010) Anna Mari Lone et al. AAPS Journal
- Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies: A retrospective analysis of the LifeLink database
- (2010) J. H. Best et al. DIABETES CARE
- Expanding the Dipeptidyl Peptidase 4-Regulated Peptidome via an Optimized Peptidomics Platform
- (2010) Arthur D. Tinoco et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Role of CD26/dipeptidyl peptidase IV in human T cell activation and function
- (2007) Kei Ohnuma Frontiers in Bioscience-Landmark
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started